$3.68
-0.09-2.39%
Last update: Nov 5, 4:00 PM
Fulcrum Therapeutics Inc
FULCNASDAQ
The average analyst price target for Fulcrum Therapeutics is $8, 117.4% above the current price. Of 11 analysts, 3 rate it Buy, 5 Hold and 3 Sell. Targets range from $3 to $24. The latest change came on Jun 3, 2026, when JP Morgan downgraded Fulcrum Therapeutics from Overweight to Underweight.
Price Target Range — 10 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
